Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Grass Pollen

PHASE3CompletedINTERVENTIONAL
Enrollment

153

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

January 31, 2013

Study Completion Date

October 31, 2013

Conditions
Seasonal Allergic Rhinitis
Interventions
BIOLOGICAL

Allergen extract (Phleum pratense)

Subcutaneous immunotherapy with modified extract of Phleum pratense. A subcutaneous monthly treatment.

BIOLOGICAL

Placebo

Subcutaneous monthly treatment

Trial Locations (23)

1122

Fövarosi Önkormányzat Szent János Kórháza és Észak-budai Egyesített, Budapest

1134

AEK Jarobetegszakrendelo Intézet Pulmonologia, Budapest

2900

Selye jános Kórhaz-Rendelöintézet Tüdögondozó Intézet, Komárom

9200

Karolina Kórhaz Rendelöintézet Tüdögondozó, Mosonmagyaróvár

28905

Hospital Universitario de Getafe, Madrid

34005

H. Río Carrión, Palencia

Unknown

Hospital Ntra. Sra de Sonsoles, Ávila

Hospital de Llerena, Badajoz

Hospital Militar de Burgos, Burgos

Hospital de Coria, Cáceres

Hospital Ntra. Sra. de la Montaña, Cáceres

Hospital Ciudad Real, Ciudad Real

Hospital San Juan de Dios, León

Hospital Virgen Blanca, León

Hospital San Millan, Logroño

Hospital de Merida, Mérida

Clinica Universitaria de Navarra, Navarra

Hospital del Bierzo, Ponferrada

Hospital Santa Barbara, Puertollano

Hospital de Santa Barbara, Soria

Hospital Universitario del Río Hortega, Valladolid

Hospital Clinico Lozano Blesa, Zaragoza

Hospital la Maz, Zaragoza

Sponsors
All Listed Sponsors
lead

Laboratorios Leti, S.L.

INDUSTRY

NCT00916422 - Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Grass Pollen | Biotech Hunter | Biotech Hunter